Dr. Reddy's Laboratories
DRREDDY · Pharma > Pharmaceuticals & Drugs · Chairman: K Satish Reddy · MD: GV Prasad · Listing date: Oct. 24, 1994 · Employees: 22739 · Hyderabad · http://www.drreddys.com

Stock Price vs Company Growth
1d
1.2%
1w
7.7%
1m
10.6%
3m
2.4%
6m
12.4%
1y
21.5%
5y
19.3%
10y
8.4%
all
13.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,342 1.2%
1,171
1,368
Company Overview

Sales
30,085 Cr
Growth: 12.2%
Profit after Tax
5,339 Cr
Growth: -4.1%
Large Cap
1,12,017 Cr
P/E: 25.8x
Industry P/E: 37.3x
Fundamentals

Sales (Cr) ₹ 30,085
Growth 12.2%
EBITDA 26.8%
P/S 3.7x
Dividend 0.8%
P/E 25.8x
Book Value ₹ 370
PEG Ratio 2.1x
ROE 18.4%
P/B 3.6x
Shareholding Pattern

Institutions
First Senter Investors Icvc- Stewart Investors Asia Pacific Leaders Sustainability Fund
3.37 %
Life Insurance Corporation Of India P & Gs Fund
2.34 %
Sbi Mutual Fund
2.11 %
Aditya Birla Mutual Fund
1.96 %
Government Of Singapore - E
1.77 %
Promoters
Dr. Reddy'S Holdings Limited
24.84 %
Gunupati Venkateswara Prasad (Huf)
0.67 %
Samrajyam Reddy Kallam
0.67 %
Satish Reddy Kallam
0.54 %
Others
Jp Morgan Chase Bank, Na
12.09 %
Icici Prudential Life Insurance Company Limited
1.38 %
Nps Trust - A/C
1.27 %
Iepf
0.14 %
Increase    Decrease    No change
Company Profile Detailed

The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Investors (382)
Followers (32)